Trase, a company building AI agents for high-stakes environments, has closed a $107 million seed funding round. ARCH Venture Partners led the investment, with Red Cell Partners and other backers participating. The capital will expand the company's workforce and accelerate development of its agentic AI operating system, already in use at Duke Health.
The Virginia-based firm, which has hubs in Seattle and Washington, D.C., operates across healthcare, government, and enterprise. Its core product, Trase Origin, is an AI Agents & Automation platform that lets organizations build purpose-specific agents without shifting data or giving up control.
How Trase Origin works
The agentic OS supports a wide range of AI for Healthcare functions. These include patient access and navigation, clinical research, resource optimization, clinician support, care pathway automation, care management, and revenue cycle management. The company says organizations can use its agents without moving their data or losing control over their systems.
"In the age of AI, powered by the sovereignty, predictability and trustworthiness that Trase's OS delivers, agents are handling the onerous, immutable tasks that bog down highly trained individuals," Grant Verstandig, CEO and cofounder of Trase, said in a statement. "Shifting that valuable mental capacity to higher-acuity work will help make the most important systems in the United States cheaper, faster and better for every American."
Automating fax triage at Duke Heart Center
Trase entered a strategic partnership with Duke University last year to build AI agents targeting administrative burdens. The first stage focused on the Duke Heart Center, where the cardiology division deployed an agent to sort more than 5,000 faxes a month-a job medical assistants and nurses previously did by hand.
"We used to show up on Monday mornings to hundreds of faxes waiting to be routed. When we first turned on the Trase fax routing agent, it processed the lion's share of them by the end of the day," said Dr. Manesh Patel, chief of the division of cardiology at Duke Health. "This work with Trase has shown us that the promise of AI in a clinical setting is real."
Why this matters for healthcare professionals
Trase Origin's design-keeping data in place while automating rote workflows-speaks directly to health systems that need compliance and control. The Duke deployment shows a concrete path to reducing administrative load for clinical staff. With $107 million in new funding, the company aims to scale those time-saving agents across more provider organizations and care settings.
Your membership also unlocks:
